Merck makes a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, consumer care and animal health products. We aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow.

Research Grants 799 show all


$33.7M
2015

$41.3M
2016

$86.7M
2017

$27.6M
2018

$46.7M
2019

Publications 14,098 show all

  • 205
    Enzyme Inhibitors/pharmacology
  • 166
    Chromatography, High Pressure Liquid/methods
  • 164
    Drug Design
  • 139
    Diabetes Mellitus, Type 2/drug therapy
  • 126
    Anti-Bacterial Agents/pharmacology
  • 110
    Mass Spectrometry/methods
  • 98
    Pyridines/pharmacology
  • 97
    Drug Discovery
  • 93
    Piperidines/pharmacology
  • 88
    Pharmaceutical Preparations/metabolism

Patents 110,749show all

  • 29,762
    C07D - Heterocyclic compounds
  • 16,851
    A61K - Preparations for medical, dental, or toilet purposes
  • 9,118
    C07C - Acyclic or carbocyclic compounds
  • 6,554
    C09K - Materials for miscellaneous applications, not provided for elsewhere
  • 5,854
    C07K - Peptides
  • 3,886
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 3,578
    H01L - Semiconductor devices
  • 2,874
    C12N - Microorganisms or enzymes
  • 2,392
    Y02E - Reduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution
  • 2,260
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Clinical Trials 5,405show all

1,427Phase 31,047Phase 2851N/A728Phase 1546Phase 4252Other

SEC Filings show all


217
8-K

78
10-Q

25
10-K

Contact Information

Kenilworth, NJ
United States